相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
The potential therapeutic use of renin-angiotensin system inhibitors in the treatment of inflammatory diseases
Reza Ranjbar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Angiotensin l-converting enzyme gene plays a crucial role in the pathology of carcinomas in colorectal cancer
Keqian Zhang et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
(Pro)renin Receptor Expression Increases throughout the Colorectal Adenoma-Adenocarcinoma Sequence and It Is Associated with Worse Colorectal Cancer Prognosis
Maider Beitia et al.
CANCERS (2019)
Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers
Tsuyoshi Ozawa et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2019)
Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence
Maider Beitia et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis
Shin Ishikane et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Renin angiotensin system and its role in biomarkers and treatment in gliomas
Alexander Perdomo-Pantoja et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma
Alexander Perdomo-Pantoja et al.
PLOS ONE (2018)
Do renin-angiotensin system inhibitors influence the recurrence, metastasis, and survival in cancer patients? Evidence from a meta-analysis including 55 studies
Hong Sun et al.
MEDICINE (2017)
AT1 receptor signaling pathways in the cardiovascular system
Tatsuo Kawai et al.
PHARMACOLOGICAL RESEARCH (2017)
Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy
Matthias Pinter et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
Juanjuan Xu et al.
FRONTIERS IN PHYSIOLOGY (2017)
Angiotensin II subtype 1a receptor signaling in resident hepatic macrophages induces liver metastasis formation
Yuki Shimizu et al.
CANCER SCIENCE (2017)
The Use of Telmisartan and the Incidence of Cancer
Koray Tascilar et al.
AMERICAN JOURNAL OF HYPERTENSION (2016)
Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry
Changhui Yu et al.
CANCER LETTERS (2016)
Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line
Elham Bakhtiari et al.
JOURNAL OF CHEMOTHERAPY (2016)
miR-205 mediates the inhibition of cervical cancer cell proliferation using olmesartan
Zhang Yue et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2016)
Ang-(1-7) promotes the migration and invasion of human renal cell carcinoma cells via Mas-mediated AKT signaling pathway
Shuai Zheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis
Yi-Ning Dai et al.
CANCER CAUSES & CONTROL (2015)
Genetic variants in the renin-angiotensin system predict response to bevacizumab in cancer patients
Diana Moreno-Munoz et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
911 A Novel Use of Angiotensin II Receptor Blocker (ARB) Losartan to Inhibit AOM Induced Tumorigenesis and Neoangiogenesis in Experimental Colon Cancer
Vesta Valuckaite et al.
GASTROENTEROLOGY (2015)
Interactions of the renin-angiotensin system in colorectal cancer and metastasis
W. Kurtis Childers
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2015)
Novel RAAS agonists and antagonists: clinical applications and controversies
CesarA. Romero et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Blockade of the renin-angiotensin system inhibits growth of colorectal cancer liver metastases in the regenerating liver
Shir Lin Koh et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
Renin-Angiotensin System Blocking Drugs
Nicolas Roberto Robles et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
The renin angiotensin system regulates Kupffer cells in colorectal liver metastases
Shu Wen Wen et al.
CANCER BIOLOGY & THERAPY (2013)
Antihypertensive medications and survival in patients with cancer: A population-based retrospective cohort study
Signy Holmes et al.
CANCER EPIDEMIOLOGY (2013)
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
Vikash P. Chauhan et al.
NATURE COMMUNICATIONS (2013)
Prognonstic impact of renin-angiotensin system blockade in localised upper-tract urothelial carcinoma
N. Tanaka et al.
BRITISH JOURNAL OF CANCER (2012)
Characterization and significance of ACE2 and Mas receptor in human colon adenocarcinoma
Stella Bernardi et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2012)
Use of angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers and cancer risk: a meta-analysis of observational studies
Chan Yoon et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Angiotensin-converting enzyme 2 acts as a potential molecular target for pancreatic cancer therapy
Lin Zhou et al.
CANCER LETTERS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals The ARB Trialists Collaboration
Koon K. Teo et al.
JOURNAL OF HYPERTENSION (2011)
Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?
T. Dolley-Hitze et al.
BRITISH JOURNAL OF CANCER (2010)
The Biology of the (Pro)Renin Receptor
Genevieve Nguyen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
The renin-angiotensin system and cancer: old dog, new tricks
Amee J. George et al.
NATURE REVIEWS CANCER (2010)
Angiotensin inhibition and malignancies: a review
T. Rosenthal et al.
JOURNAL OF HUMAN HYPERTENSION (2009)
The renin-angiotensin system and malignancy
Eleanor I. Ager et al.
CARCINOGENESIS (2008)
Renin-angiotensin system revisited
F. Fyhrquist et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Structural modification of the P2′ position of 2,7-dialkyl-substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamides:: The discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets
Juergen Maibaum et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases
Jaclyn H. Neo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Differential roles of angiotensinogen and angiotensin receptor type 1 polymorphisms in breast cancer risk
A. M. Gonzalez-Zuloeta Ladd et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Inhibition of human lung cancer cell growth by angiotensin-(1-7)
PE Gallagher et al.
CARCINOGENESIS (2004)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure:: the CHARM-Overall programme
MA Pfeffer et al.
LANCET (2003)
Angiotensin-I-converting enzyme and its relatives
JF Riordan
GENOME BIOLOGY (2003)
Angiotensin II type 1 receptor blockers
M Burnier
CIRCULATION (2001)
Angiotensin II receptor antagonists
M Burnier et al.
LANCET (2000)
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer
CR Meier et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
分享论文
